354 related articles for article (PubMed ID: 23824801)
1. Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development.
Du L; Zhao G; Kou Z; Ma C; Sun S; Poon VK; Lu L; Wang L; Debnath AK; Zheng BJ; Zhou Y; Jiang S
J Virol; 2013 Sep; 87(17):9939-42. PubMed ID: 23824801
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
[TBL] [Abstract][Full Text] [Related]
3. A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein.
Du L; Zhao G; Yang Y; Qiu H; Wang L; Kou Z; Tao X; Yu H; Sun S; Tseng CT; Jiang S; Li F; Zhou Y
J Virol; 2014 Jun; 88(12):7045-53. PubMed ID: 24719424
[TBL] [Abstract][Full Text] [Related]
4. Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design.
Ma C; Wang L; Tao X; Zhang N; Yang Y; Tseng CK; Li F; Zhou Y; Jiang S; Du L
Vaccine; 2014 Oct; 32(46):6170-6176. PubMed ID: 25240756
[TBL] [Abstract][Full Text] [Related]
5. Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection.
Jia W; Channappanavar R; Zhang C; Li M; Zhou H; Zhang S; Zhou P; Xu J; Shan S; Shi X; Wang X; Zhao J; Zhou D; Perlman S; Zhang L
Emerg Microbes Infect; 2019; 8(1):760-772. PubMed ID: 31130102
[TBL] [Abstract][Full Text] [Related]
6. A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection.
Tai W; Zhao G; Sun S; Guo Y; Wang Y; Tao X; Tseng CK; Li F; Jiang S; Du L; Zhou Y
Virology; 2016 Dec; 499():375-382. PubMed ID: 27750111
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization.
Kleine-Weber H; Elzayat MT; Wang L; Graham BS; Müller MA; Drosten C; Pöhlmann S; Hoffmann M
J Virol; 2019 Jan; 93(2):. PubMed ID: 30404801
[TBL] [Abstract][Full Text] [Related]
8. Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines.
Ma C; Li Y; Wang L; Zhao G; Tao X; Tseng CT; Zhou Y; Du L; Jiang S
Vaccine; 2014 Apr; 32(18):2100-8. PubMed ID: 24560617
[TBL] [Abstract][Full Text] [Related]
9. Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4.
van Doremalen N; Miazgowicz KL; Milne-Price S; Bushmaker T; Robertson S; Scott D; Kinne J; McLellan JS; Zhu J; Munster VJ
J Virol; 2014 Aug; 88(16):9220-32. PubMed ID: 24899185
[TBL] [Abstract][Full Text] [Related]
10. Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies.
Song F; Fux R; Provacia LB; Volz A; Eickmann M; Becker S; Osterhaus AD; Haagmans BL; Sutter G
J Virol; 2013 Nov; 87(21):11950-4. PubMed ID: 23986586
[TBL] [Abstract][Full Text] [Related]
11. A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines.
Du L; Kou Z; Ma C; Tao X; Wang L; Zhao G; Chen Y; Yu F; Tseng CT; Zhou Y; Jiang S
PLoS One; 2013; 8(12):e81587. PubMed ID: 24324708
[TBL] [Abstract][Full Text] [Related]
12. The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection.
Jiaming L; Yanfeng Y; Yao D; Yawei H; Linlin B; Baoying H; Jinghua Y; Gao GF; Chuan Q; Wenjie T
Vaccine; 2017 Jan; 35(1):10-18. PubMed ID: 27899228
[TBL] [Abstract][Full Text] [Related]
13. Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution.
Tang XC; Agnihothram SS; Jiao Y; Stanhope J; Graham RL; Peterson EC; Avnir Y; Tallarico AS; Sheehan J; Zhu Q; Baric RS; Marasco WA
Proc Natl Acad Sci U S A; 2014 May; 111(19):E2018-26. PubMed ID: 24778221
[TBL] [Abstract][Full Text] [Related]
14. A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model.
Hashem AM; Algaissi A; Agrawal AS; Al-Amri SS; Alhabbab RY; Sohrab SS; S Almasoud A; Alharbi NK; Peng BH; Russell M; Li X; Tseng CK
J Infect Dis; 2019 Oct; 220(10):1558-1567. PubMed ID: 30911758
[TBL] [Abstract][Full Text] [Related]
15. Spread of Mutant Middle East Respiratory Syndrome Coronavirus with Reduced Affinity to Human CD26 during the South Korean Outbreak.
Kim Y; Cheon S; Min CK; Sohn KM; Kang YJ; Cha YJ; Kang JI; Han SK; Ha NY; Kim G; Aigerim A; Shin HM; Choi MS; Kim S; Cho HS; Kim YS; Cho NH
mBio; 2016 Mar; 7(2):e00019. PubMed ID: 26933050
[TBL] [Abstract][Full Text] [Related]
16. Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
Choi JA; Goo J; Yang E; Jung DI; Lee S; Rho S; Jeong Y; Park YS; Park H; Moon YH; Park U; Seo SH; Lee H; Lee JM; Cho NH; Song M; Kim JO
J Virol; 2020 Nov; 94(24):. PubMed ID: 32967955
[TBL] [Abstract][Full Text] [Related]
17. The receptor binding domain of MERS-CoV: the dawn of vaccine and treatment development.
Zhou N; Zhang Y; Zhang JC; Feng L; Bao JK
J Formos Med Assoc; 2014 Mar; 113(3):143-7. PubMed ID: 24342026
[TBL] [Abstract][Full Text] [Related]
18. Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus.
Kim MH; Kim HJ; Chang J
PLoS One; 2019; 14(7):e0220196. PubMed ID: 31329652
[TBL] [Abstract][Full Text] [Related]
19. The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies.
Mou H; Raj VS; van Kuppeveld FJ; Rottier PJ; Haagmans BL; Bosch BJ
J Virol; 2013 Aug; 87(16):9379-83. PubMed ID: 23785207
[TBL] [Abstract][Full Text] [Related]
20. A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV.
Zhao G; Du L; Ma C; Li Y; Li L; Poon VK; Wang L; Yu F; Zheng BJ; Jiang S; Zhou Y
Virol J; 2013 Aug; 10():266. PubMed ID: 23978242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]